Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
September 22, 2013
Supernus & Catalent Enter Supply Agreement
Catalent Pharma Solutions and Supernus Pharmaceuticals recently announced they have entered into an agreement in which Catalent is the supplier...
September 9, 2013
TesoRx & CoreRx Announce Lucrative Joint Venture
TesoRx Pharma, LLC and CoreRx, Inc. recently announced a manufacturing joint venture to produce TSX-002, a first-in-class oral testosterone drug...
September 5, 2013
BIOAVAILABILITY ENHANCEMENT - Navigating a Broad Spectrum of Solubilization Technologies: Part I of III
In the past two columns, The Second Quadrant focused on excipients and the roles they play in the quest to...
September 5, 2013
TOPICAL TRENDS - Trends in Skin Medication Dispensing
Stefan Hellbardt, PhD, and Degenhard Marx, PhD, focus their review on the trends in topical skin medication, the impact on primary packaging, and possible dispensing solutions.
August 27, 2013
InSite Vision Announces Patent Issuance on Ophthalmic Delivery System
InSite Vision Incorporated recently announced the United States Patent and Trademark Office (USPTO) has issued US Patent No. 8,501,800 on...
August 20, 2013
MultiCell Technologies & Genisphere Evaluate Targeted Delivery of MCT-485 for Cancer
MultiCell Technologies, Inc. and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of...
July 20, 2013
SPECIAL FEATURE - Transdermal, Topical & Subcutaneous Drug Delivery: Extending Pipelines & Improving Self-Administration
Contributor Cindy H. Dubin explores how the movement of home care and self- administration is pushing the development of this growing sector in drug delivery.
July 10, 2013
BIOAVAILABILITY ENHANCEMENT - Out of the Shadows: Excipients Take the Spotlight; Part 2 of 2
In June’s edition of The Second Quadrant, we heard from leading excipient providers about challenges faced directly related to formulating...
July 8, 2013
Glide Pharma Announces Design Optimization Agreement With Nypro Healthcare
Glide Pharma recently announced it has entered an agreement with global device manufacturer Nypro Healthcare to complete the design optimization...
June 10, 2013
MARKET BRIEF - Controlled Release Technologies: Advancing Toward Targeting Therapeutics
Frost & Sullivan Analyst Cecilia Van Cauwenberghe, MS, reviews a few recent innovative approaches to controlled release technologies with a focus on some of the therapeutic areas most relevant to the current pharmaceuticals market.
